Medical Journals

Effects of Monotherapy and Combination Therapy on Blood Pressure Control and Target Organ Damage: a Randomized Prospective Intervention Study in a Large Population of Hypertensive Patients.

Authors:
  • Tedesco Michele Adolfo
  • Natale Francesco
  • CalabrĂ² Raffaele

From: Division of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy. tedesco@pandoranapoli.it

Journal of clinical hypertension (Greenwich, Conn.)

  • Publish Date: Sep 2006
  • ISSN: 1524-6175
  • Volume: 8
  • Issue: 9
  • Pages: 634-41
  • Medium: Print
  • Language: English
  • Citation (JAMA): Tedesco Michele Adolfo, Natale Francesco, CalabrĂ² Raffaele, et al. Effects of Monotherapy and Combination Therapy on Blood Pressure Control and Target Organ Damage: a Randomized Prospective Intervention Study in a Large Population of Hypertensive Patients.. Sep 2006;8:634-41

Abstract

This prospective, randomized trial evaluated the effect of monotherapy and different combination therapies on cardiovascular target organ damage and metabolic profile in 520 hypertensive patients. Patients were allocated to a single agent: carvedilol 25 mg, amlodipine 10 mg, enalapril 20 mg, or losartan 50 mg (groups C, A, E, and L, respectively). After 2 months (level 2), nonresponders received a low-dose thiazide diuretic, and after 4 months (level 3), amlodipine (groups E, C, and L) and carvedilol (group A). Twenty-four-hour blood pressure was significantly lowered in all treatment groups. Blood pressure control was more pronounced in patients receiving two or three drugs. At the end of the study, the carotid intima-media thickness decreased in group L (P<.01), left ventricular mass index in groups E and L (P<.05 and P<.001, respectively), with a concomitant reduction in cholesterol in group L (P<.03). Diastolic function improved significantly in group L (P<.05). This study describes the need to control blood pressure with two or more drugs in most hypertensive patients and illustrates good clinical outcomes, independent of blood pressure lowering, using combination therapy with losartan, low-dose thiazide, and amlodipine.

Mesh Headings (Keywords): Adult, Aged, Aged, 80 and over, Amlodipine, Antihypertensive Agents, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Carbazoles, Cardiovascular Diseases, Drug Therapy, Combination, Enalapril, Humans, Hypertension, Losartan, Male, Middle Aged, Propanolamines


Check for Full Text / PubMed Unique Identifier (PMID): 16957425


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.